Black Diamond Therapeutics, Inc. BDTX

1.88 (0.02) (1.05%) as of 25 Sep

Follow BDTX

Cash Flow Champion (3y)

Growth Flags show if company had growth for consecutive years

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(37.21%)	(35.16%)	22.88%	19.23%	+8 more TTM periods Free account
ROA Full definition →	(29.21%)	(27.95%)	16.84%	14.54%
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(42.61%)	(39.73%)	19.11%	17.26%
Free Cash Flow per Share Full definition →	(0.57)	(0.59)	0.52	0.38
Free Cash Flow Full definition →	(32.84)	(34.03)	29.64	21.38
Capital Expenditures Full definition →	—	—	0.03	0.03
Other line items
Cash ROIC Full definition →	(15.89%)	(15.29%)	12.29%	8.16%
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	0.77	0.79	1.32	0.99
Depreciation/Fixed assets Full definition →	0.67	0.78	0.89	0.31
Capex/Depreciation Full definition →	0.00	0.00	0.08	0.09
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.57)	(0.59)	0.52	0.38
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	—	—	0.00	0.00
Net Profit Margin Full definition →	0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack